Cite
HARVARD Citation
Chen, F. et al. (2022). Salvage of refractory post‐transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab. Transfusion medicine. 32 (5), pp. 437-440. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chen, F. et al. (2022). Salvage of refractory post‐transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab. Transfusion medicine. 32 (5), pp. 437-440. [Online].